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Celiac disease is characterized by an allergic reaction to gluten that causes
inflammation of the small intestine and can lead to malabsorption and malnutrition.
Gluten-free products are being developed that meet dietary needs of individuals with
celiac disease. However, these products often lack whole grains and fiber. Fortification
of gluten-free products with flax can increase nutritional value and alleviate
inflammation. Sensory analysis (N=152) was conducted to evaluate the acceptability of
gluten-free muffins with moderate (3.8%) and high (7.4%) amounts of added flax.
Results indicated that consumers preferred (p<0.05) the muffin without flax or the highflax muffin more than the muffin with the moderate-flax treatment. The high-flax and
control treatments were rated 6.7, between like slightly and moderately like; the muffins
from the moderate-flax treatment were rated 6.4 on a nine-point hedonic scale. Producers
of gluten-free products could potentially formulate muffins that include flax and are
acceptable to consumers.
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CHAPTER I
INTRODUCTION
Celiac disease and gluten-sensitive enteropathy are becoming more prevalent
worldwide (Logan & Bowlus, 2010) as dietary patterns and genetic predisposition
become more widespread. These conditions are characterized by chronic allergic
reaction to common cereal proteins that causes inflammation of the small intestine
(Owens & Greenson, 2007). This chronic inflammation can lead to underlying
malabsorption and malnutrition. Gluten-free products are currently a popular trend not
only in terms of nutrition, but in terms of food product and market development (Lee, Ng,
Zinvin, & Green, 2007). There are currently hundreds of new food products that cater to
individuals with celiac disease and gluten allergy. While complete avoidance of gluten
can be obtained through gluten-free products, nutritious fortified products are usually
lacking in the marketplace. Gluten-free products generally are devoid of whole grains.
Fortification of gluten-free products with other naturally occurring gluten-free ingredients
can allow for greater variety of nutrient-rich foods, and also help alleviate chronic
symptoms associated with celiac disease inflammation.
Flax, Linum usitatissimum, has recently been classified as a functional food
because of its high content of lignans, polyunsaturated fatty acids, and alpha-linolenic
acid, an essential fatty acid (Pan, Yu, Demark-Wahnefried, Fanco, & Lin, 2009). These
compounds are associated with reduction in cardiovascular disease and cancer, and have
anti-inflammatory properties (Heller, Rossler, Stehr, Heller & Koch, 2006). While
1

numerous benefits of flax have been studied, many of these applications are often not
useful to individuals with gluten-sensitive enteropathy or celiac disease because flax is
generally utilized in baked products containing gluten. The purpose of this study was to
develop an acceptable gluten-free muffin with added flax. The objectives were to 1)
determine an acceptable amount of flax to fortify gluten-free muffins, and 2) develop an
acceptable gluten-free muffin that would provide the nutritious benefits of flax and also
be rated favorably by consumers.
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CHAPTER II
REVIEW OF LITERATURE
Celiac Disease
The occurrence and treatment of celiac disease is becoming more common in the
field of medicine, nutrition, and epidemiology. Also known as celiac sprue or glutensensitive enteropathy, celiac disease is a malabsorption syndrome that involves a severe
allergic reaction following the ingestion of wheat or gluten-containing compounds. It,
however, should not be confused for a simple food allergy. Food allergies are IgE
mediated (Mahan & Escott-Stump, 2004) and symptoms generally subside after the
causative protein is removed. In celiac disease, the gluten protein causes an initiation of
immune response that affects the body in several ways including malabsorption and
inflammation. Celiac disease is a self-perpetuating condition and recuperation from
symptoms can take weeks to years.
It has been suggested that 1:100 people in Western Europe and North America
have celiac disease. Genetics plays a large part in regional susceptibility in addition to
normal dietary patterns (Owens & Greenson, 2007). However, as people and cultural
eating practices become more integrated and widespread, so does the incidence of celiac
disease; prevalence is growing in Eastern cultures of Asia and the Caribbean. Even with
increased public awareness, it is hypothesized that a majority of the cases worldwide are
still under-diagnosed (Reeves & Leibovici, 2005). The worldwide incidence of celiac
disease has climbed from 0.1% to 1% in the past decade, probably as a result of the
3

medical community’s awareness and improved testing techniques (Kaukinen, Lindfors,
Collin, Koskinen, & Maki, 2010). The fact that the incidence has risen so quickly in a
relatively short period of time indicates that genetics is not the only factor involved.
Kaukinen and colleagues (2010) postulate that the increase in celiac disease is not only
related to genetics but also infant feeding practices, rotavirus infection, socioeconomic
status, and environmental exposure to antigens.
Introduction of gluten before four months of age has been associated with
increased risk of developing celiac disease (Norris, et al., 2005). In Sweden, there was an
increased incidence of two-year-old children diagnosed with celiac disease in 1985-1987
and a subsequent decline in 1995-1997, which has been suggested to be related to popular
infant feeding practices of the time (Lohi, et al., 2007), length of breastfeeding, and initial
age of adding gluten into the diet (Sollid, 2000). The Hygiene Hypothesis theorizes that
as our world has industrialized, we are more sheltered from microbial and antigen contact
as children and unfortunately this has led to decreased humoral response. This can
perhaps explain the body’s up-regulation of food allergies later in life (Kaukinen, et al.,
2010). The incidence of celiac disease has risen at a linear rate that is similar to
autoimmune disorders such as insulin-dependent diabetes mellitus (Lohi, et al., 2007)
with women comprising roughly 75% of newly diagnosed adult cases (Corrao, et al.,
2001).
Gluten is a grass protein that consists of specific peptide fractions in wheat, rye,
and barley (Mahan & Escott-Stump, 2004). The alcohol-soluble fractions of gluten are
gliadin in wheat, hordeins in barley, and secalins in rye and are causative antigens in the
celiac disease immune response. Wheat is a staple of the Western diet with the amount
of gluten consumed per individual at approximately 10-20gms/day (Kaukinen, et al.,
4

2010). Gluten is also found in commonly used products such as cosmetics, medicines,
emulsifiers, beer, and many processed foods. With the widespread usage of gluten in
foods and other products, a diet completely eliminating gluten may not be possible
(Storsrud, Yman, & Lenner, 2003); however, a safe threshold has been 10-50µg/day,
much less than the average consumer intake in western culture (Catassi & Fasano, 2008).
Unfortunately, the exact peptide sequence that causes an immune reaction has yet to be
discovered (Owens & Greenson, 2007), but it is known that the peptide sequence is rich
in glutamine and proline amino acids.
For people with celiac disease, an immune response occurs when gluten is
ingested. Symptoms may be mild to severe depending on the age of the individual,
duration of contact with gluten, and the extent of long-term damage to the small intestinal
mucosa (Bassotii, et al., 2007). The extent of symptoms is not directly correlated with
severity of mucosal damage but rather the quantity of damaged mucosal tissue
(Kaukinen, et al., 2010). The symptoms are characteristic of gastritis such as abdominal
discomfort, bloating, constipation, nausea, and/or diarrhea. Often times, the symptoms
are overlooked as indigestion, food intolerance or irritable bowel syndrome (IBS)
(Kaukinen, et al., 2010). External symptoms can also occur such as skin and liver
conditions. Dermatis herpetiformis is common and involves large blisters on the skin and
usually is not accompanied with abdominal discomfort. These blisters itch and most
commonly appear on the scalp, elbows, and buttocks (Kaukinen, et al., 2010).
Hepatopathy generally is mild and subsides immediately after removal of gluten from the
diet. The symptoms can however take up to three months to fully dissipate (Owens &
Greenson, 2007).
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The integrity of the small intestine is compromised when symptoms are present.
This unfortunately decreases the absorption of not only the offending gluten peptides, but
other nutrients as well. Celiac disease is characterized by chronic inflammation that can
cause nutrient sludge in the gut. This sludge then passes through the ileum to the colon
and then out of the body with poor absorption of energy nutrients, vitamins, and minerals.
Steatorrhea occurs when the fecal material has large concentrations of maldigested fat.
This quick passage of material through the alimentary canal does not allow adequate time
for nutrient uptake and can cause the individual to be deficient in energy, carbohydrates,
protein, essential fatty acids, fat soluble vitamins A, D, E and K, and also folate, iron,
calcium, and vitamin B12. Over time, symptoms of malnutrition may become apparent
such as hypoalbuminemia, growth delay, weight loss, and failure to thrive.
Megaoloblastic anemia may also occur as adequate folate is not absorbed, and iron
deficiency anemia may occur as well. Many times adult patients do not present to their
physicians with classic symptoms of celiac disease, but rather symptoms of anemia or
poor coagulation from inadequate vitamin K absorption (Owens & Greenson, 2007).
Inappropriate calcium absorption can lead to rickets in pediatric patients (Ensari, 2010)
and decreased bone mineral density and osteoporosis in adults (Capriles, Martini, &
Areas, 2009). Children with prolonged malnutrition from poor absorption are at risk for
delayed puberty and failure to reach full growth potential (Owens & Greenson, 2007).
Other complications of malabsorption and nutrient deficiency are infertility, neurological
deficits, decreased skin integrity, increased risk for Non-Hodgkin’s lymphoma,
gastrointestinal cancer, and mortality (Sollid, 2000).
The susceptibility to gluten antigens relies heavily on genetic makeup. The
human leukocyte antigen (HLA) haplotypes, HLA-DQ2 and HLA-DQ8, are associated
6

with manifestation of celiac disease (Green & Cellier, 2007; Plenge, 2010). Individuals
that have the HLA phenotype possess the allele to synthesize and express HLA-DQ2 or
HLA-DQ8 proteins. Karell and colleagues (2003) reported that there is increasing
evidence for the presence of additional risk variants on different chromosomes.
Individuals that do not have the HLA halpotype cannot express these proteins, and it is
unlikely that they are susceptible to gluten antigens, which makes HLA-typing useful for
exclusion purposes (Karell, et al., 2003). Unfortunately, 40% of the general population is
HLA-positive so this genetic sequencing cannot be used for definitive diagnosis of celiac
disease. The primary haplotype expressed in individuals with celiac disease is HLA-DQ2
(88%) and the remainder is HLA-DQ8 (Sollid, 2000). This haplotype is also associated
with type 1 diabetes, Addison syndrome, and Sjögren’s syndrome (Haines, Anderson, &
Gibson, 2008). Homozygocity for the HLA phenotypes is much more efficient at
expressing antigens to gluten than heterozygous HLA, which may explain the varying
degree and severity of symptoms in active celiac disease (Vader, et al., 2003).
Historically characterized as a childhood disease, the age of celiac disease
diagnosis has shifted upward over the past twenty years (Kaukinen, et al., 2010).
Susceptibility to a wheat protein immune response can occur at any age. The diagnosis
was first characterized by Dr. Samuel Gee, an English pediatrician, in 1888. It originally
presented in children with diarrhea, lassitude, malabsorption, and failure to thrive
(Kaukinen, et al., 2010). In general, infants and children can present with diarrhea,
abdominal distention, failure to thrive, vomiting, irritability, anorexia, and constipation.
Infants are usually diagnosed between nine and twenty-four months of age (Capriles, et
al., 2009), and symptoms worsen as more cereals are introduced into their diets (Owens
& Greenson, 2007). Toddlers and children generally present with extraintestinal skin
7

anomalies, short stature, neurological deficits, and anemia (Green & Cellier, 2007).
Early intervention with children usually results in complete mucosal healing (Lanzini, et
al., 2009), and if detected before puberty, peak bone mineral density can still be reached
(Capriles, et al., 2009). Adolescents generally present with symptoms of dermatis
herpetifromis and symptoms of abdominal discomfort; they have a good chance of bone
remineralization assuming they follow a gluten-free diet (Capriles, et al., 2009).
Unfortunately, adolescences have the lowest level of diet compliance of any age group
(Mayer, Greco, Troncone, Auricchio, & Marsh, 1991).
Adults generally present with less common symptoms such as hypocalcaemia,
elevated liver function tests, and hypoalbuminemia as well as diarrhea, abdominal pain,
constipation, and weight loss (Green & Cellier, 2007). Diagnosis of celiac disease is
often made in the third and fourth decades of life (Capriles, et al., 2009) as an overlying
diagnosis to several nonspecific symptoms. Bone mineral density rarely returns to
normal levels in adults with chronic celiac-related malabsorption simply because the
small intestinal mucosa has lost functionality due to continuous inflammation. Geriatric
patients surprisingly present with milder symptoms of abdominal discomfort and flatus.
A study by Mukherjee, Luyer, Heineman, and Buurman (2010) compared clinical
presentation, bone mineral density, duration, and small intestinal histology of individuals
with celiac disease of two different age groups of active celiac disease patients: ≥65 years
old and 18-30 years old; they found that both groups were histologically similar with no
difference in degree of villous atrophy regardless of duration of diagnosis. This study
suggested that most individuals with celiac disease have had it their entire life and did not
develop it over time (Makherjee, et al., 2010).
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Celiac disease is a T-cell mediated disease. Innate immunity via T-lymphocytes
plays a part in intestinal damage and malabsorption (Murray, 1999). When gluten is
ingested, it enters the alimentary canal and is broken into its component peptides,
including gliadin (Shan, et al., 2002). Gliadin is then taken up by HLA+ cells and
presented on their surface in the lamina propria. In the lamina propria, gliadin can exist
in the native form or the deamidated form by tissue transglutaminase (tTG). When
gliadin is presented on the HLA in the lamina propria, it simultaneously activates the
CD4+ T-lymphocytes (Ensari, 2010) and activates the expression of interleukin-15
(Sollid, 2000). The activated CD4+ T-lymphocytes release cytokines and interleukins,
and then migrate to the surface. The expression of interleukin-15 (IL15) activates
intraepithelial lymphocytes (IELs) when the T-lymphocytes reach the surface of the
epithelium, which is the cause of inflammation (Owens & Greenson, 2007).
Humoral response is activated when gliadin is deamidated by tTG. The Blymphocytes produce and secrete IgA and IgG antibodies into the intestinal lumen aimed
at destroying gliadin, tTG, and connective tissue auto-antigens including antiendomysial
cells (Owens & Greenson, 2007). The endomysium is a sheath of connective tissue and
reticular fibrils that surround the small intestinal muscle fibers. Antiendomesial
antibodies and tTG correlate to the amount of tissue damage.
Overall, celiac disease is a disorder of the proximal small intestine that presents in
several patchy areas of inflammation along the intestinal brush border (Murray, 1999).
The inflammation is contained along the absorptive surfaces, or villi, and is the main site
of malabsorption in the small intestine. Under normal circumstances, the intestinal villi
are small finger-like projections that are equipped with digestive enzymes on their
surface. These enzymes help break the fragments of food particles into smaller entities
9

that can enter circulation. The villi are also equipped with a network of lymphatic vessels
that provide direct access to circulation (Owens & Greenson, 2007). However, when a
person with celiac disease comes into contact with gluten protein fractions, the immune
response produces a cascade of biochemical reactions that not only target the offending
allergen, but also causes damage to the body’s own tissues in an effort to destroy the
gluten antigen. Upon ingestion of gluten, T-cells release inflammatory cytokines to the
duodenum. When this happens, the villi become inflamed and are not able to function
properly. The villi are unable to absorb nutrients because of decreased exposure of
villous mass. This causes delayed transit time of the small intestine and lack of exposure
to digestive enzymes. Over time, this can lead to deficiencies in nutrients including the
essential alpha-linolenic and linoleic fatty acids (Solakivi, Kaukinen, Kunnas, Lehtimaki,
Maki, & Nikkari, 2009).
The level of duodenal damage relies heavily on the genetic susceptibility of the
person, the amount of gluten exposure, and the duration of exposure. Small intestinal
damage has been described by Marsh (1992) in what is known as the Marsh Criteria.
Marsh (1992) classified celiac-related inflammation into four categories: Types 0-III.
Type 0 is described as the absence of lesions; this is descriptive of a small intestine of an
individual without celiac disease or a person with celiac disease with a tightly controlled
diet void of gluten. Type I lesions are also known as the infiltrative state. At this point
of gluten exposure, gastrointestinal symptoms and malabsorption are not present; there is
simply an infiltration in the villi of intraepithelial leukocytes. After further exposure,
Type II, or hyperplasic lesions develop in which the IELs are still present and crypt
spaces have enlarged. Type III lesions are considered completely atrophied with
persistent IEL presences.
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While the Marsh Criteria are helpful in confirmation of celiac disease, histology is
not the final word in diagnosis. The symptoms of villous atrophy and crypt cell
hyperplasia are not pathognomonic to the condition. These pathological findings are
characteristic, but non-specific (Green & Cellier, 2007). Other conditions with similar
presentation to celiac disease include rotavirus infection and giardiasis (Kaukinen, et al.,
2010). It has been hypothesized that celiac disease is often mistakenly suspected by
patients who suffer from chronic Helicobacter pylori infections, other food allergies, and
Crohn’s disease; all of these have similar histology to celiac disease (Ensari, 2010). It
has been demonstrated that the amount of bacteria present in the small intestine of active
celiac patients is up to 30% higher than controlled celiac disease (Sollid, 2000). The
general consensus is that the body’s immune system is compromised to a level that
cannot keep bacteria such as H. pylori to manageable levels because of the gluten
exposure and diminished immune function.
Correct diagnosis of celiac disease is essential because it requires that the
individual follow gluten-free protocols for the rest of his or her life (Bhatnagar &
Tandon, 2006). It is important that the medical practitioner consider the diagnosis of
celiac disease seriously because compliance with the gluten-free diet is not only
expensive, it is socially inconvenient (Green & Cellier, 2007). Patients often present with
generic symptoms of gastrointestinal complications; many patients self-diagnose
themselves with celiac disease and begin following a gluten-free diet before seeking
medical attention. Many patients do not experience classic symptoms of celiac disease
(Fasano, et al., 2003). Resolved symptoms after following a gluten-free diet is not
sufficient evidence to make a definitive diagnosis because the symptoms of celiac disease
are similar to that of IBS, Crohn’s disease, and ulcerative colitis (Campanella, Biagi,
11

Bianchi, Zanellati, Marchese, & Corazza, 2008). The severity of the disease in a
prolonged active state necessitates early diagnosis. Normalization of the small intestine
is more likely to occur for individuals that have not had prolonged gluten exposure and
villous inflammation (Lanzini, et al., 2009).
Diagnostic criteria involved in the diagnosis of celiac disease include serological
antibody testing, histological evidence, and reduction of symptoms after following a
gluten-free diet. Unfortunately, there is not currently a consensus in the medical
community on precise criteria needed for a celiac disease diagnosis. The American
Gastroenterological Association mandates that biopsies be preformed regardless of
serological findings, in any patient that is suspected to have gluten-sensitive enteropathy.
The U.S. National Institutes of Health, however, only recommends biopsies to confirm
positive serological findings. Serological testing relies on antibodies produced in
response to gluten ingestion. Recent advances in serological antibody testing have shown
that celiac disease is much more common than once thought (Haines, et al., 2008).
Presence of specific antibodies can reveal that the body has produced an immune
response to gluten. Humoral response to gluten produces antibodies against the
offending gluten molecules and antibodies against the body’s own tissues. It is possible
to detect antibodies specific to gluten molecules. This method uses an assay to detect
native gliadin antibodies but is no longer useful for diagnostic practices because the test
lacks sensitivity and specificity, and the chances for false negatives and false positives
are too high (Kaukinen, et al., 2010). Early serological diagnostic for celiac disease autoantibodies involving immunofluorescent assay (IFA) can be utilized to test for antiendomysial antibodies. This test is highly specific to antigens only produced in active
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celiac disease. However, this test requires a trained technician and relies on subjective
interpretation of results for diagnosis (Ensari, 2010).
It is now customary to use an enzyme-linked immunosorbent assay (ELISA)
method to test for tTG antibodies (Owens & Greenson, 2007). The ELISA test for tTG
antibodies can be performed in an office and does not require subjective assessment
(Green & Cellier, 2007). This test is also more sensitive than the IFA endomysial
antibody test and is much less expensive. Often times, the IFA test is used in conjunction
with the ELISA test for confirmatory purposes (Kaukinen, et al., Maki, 2010). Positive
serological testing with negative histological findings may be an indicator of early celiac
disease. While serotesting has been essential in the diagnosis of celiac disease, it does
not provide enough evidence for a diagnosis of celiac disease except in pediatric patients
(Kaukinen, et al., 2010); a presumptive diagnosis can be made with positive serotesting
but histological evidence is a must.
A diagnostic tool that is considered by some as the “gold-standard” is through
pathological studies of the small intestine. Given the patchy nature of celiac disease
inflammation, it is recommended that four to six endoscopic tissue samples be biopsied
from the duodenum. These samples can be evaluated for villous atrophy and crypt cell
hyperplasia (Kaukinen, et al., 2010). The presence of intraepithelial lymphocytes within
the villous crypts can also be detected histologically and are indicative of celiac disease
(Owens & Greenson, 2007). A final diagnosis of celiac disease cannot be made until
there have been positive serological tests confirmed by histological evidence along with
resolved gastrointestinal symptoms after following a gluten-free diet. Once a diagnosis is
determined, the patient should be assessed for nutritional deficiencies and should undergo
nutrition counseling by a registered dietitian and, if possible, attend celiac disease support
13

group meetings. Customary treatment of celiac disease is lifelong adherence to a glutenfree diet. The patient should be reassessed and re-biopsied in four to six months to
monitor for new inflammation and intestinal damage (Kaukinen, et al., Maki, 2010).
Serological testing is useful for determining compliance in the avoidance of gluten. It is
important to note that approximately 5% of patients do not respond to gluten-free diets
and are classified as having refractory sprue (Schuppan, Dennis, & Kelley, 2005); the
prognosis for refractory sprue is poor.
Much research has been conducted on the effectiveness of gluten-free diets. It is
hypothesized by some that gluten does not actually cause tissue injury itself, but
inflammatory chemokines cause the most damage (Owens & Greenson, 2007). However,
gluten avoidance is currently the only effective treatment for the management of celiac
disease. It is generally accepted that not only can gluten avoidance improve symptoms,
but also improve nutrition status related to absorption and prevent long-term
complications of persistent inflammation. The focus of gluten-free diets is to avoid all
varieties of wheat including smelt, kamut, and triticale as well as derivatives such as rye
and barley (Schuppan, et al., 2005). Gluten-free diets are generally successful in
reducing gastrointestinal distress in patients with celiac disease. In severely ill patients,
symptoms subside dramatically (Bassotii, et al., 2007). Resolved symptoms however do
not reflect complete healing of the small intestine. Avoidance of gluten decreases the
number of IELs and allows for reconstitution of the intestinal villi (Owens & Greenson,
2007). Healing of the small intestine usually occurs in a distal to proximal direction
(Ensari, 2010). However, the linkage to intestinal damage and resolution of symptoms
are strongly evident in symptomatic celiac disease patients (Carroccio, et al., 2008). One
study reported patients that followed gluten-free diets always had partial remission
14

periods but still expressed high numbers of IELs (Lanzini, et al., 2009). In the
retrospective study, Lanzini and colleagues (2009) also found that architectural
normalization occurred but mucosal abnormalities still persisted in adults with celiac
disease; they proposed that complete normalization occurs in only 8% of adults while
65% had periods of normalization with remission, and 1% had complete deterioration of
the villi even after following a gluten-free diet. A study by Basotti et al. (2007)
determined patients with celiac disease did not return to normal levels of mucosal
function in adults even after twenty-four months on a gluten-free diet.
Gluten-Free Diet
Research in the area of gluten-free dietary practices has shifted focus. Formerly,
the point-of-interest was pinpointing specific peptides to be avoided so as to prevent
celiac disease exacerbation. The new focus has moved to improving the nutritional
quality of the gluten-free diet. Exclusion of gluten proteins, which are a staple in many
parts of the world, may lead to exclusion of essential nutrients. Many gluten-free
products, such as cereals, pastas, and breads, are not enriched or fortified with vitamins
and minerals. Overall, folate content was lower in gluten-free breads when compared to
breads containing gluten (Yazynina, Johansson, Jägerstad, & Jastrebova, 2008).
Thompson (2000) also reported that only three gluten-free cold cereals were enriched
with folic acid out of 58 gluten-free products, which included breads, pastas, and cold
cereals. Additionally, only nine of the 58 products were enriched with iron (Thompson,
2000). This affects the dietary intake of people with celiac disease. Stanley, Gonzales,
Carroll, Nelson, and Hakkak (2010) reported significantly less niacin and carbohydrate
intakes in people following a gluten-free diet when compared to national averages as
15

determined by data from the National Health and Nutrition Examination Survey
(NHANES). Females on a gluten free diet also had less thiamin and iron when compared
to NHANES than females not on a gluten-free diet. It was concluded that additional
focus was needed on obtaining adequate amounts of B vitamins, fiber, iron, and
carbohydrate intakes for individuals following gluten-free diets (Stanley et al., 2010).
Adhering to a gluten-free diet is difficult as gluten is a widely used protein in
commercial bakery and food production. Not only does it serve as the main structural
protein of dough, it gives bread products their characteristic texture (Brown, 2008).
Gluten is also employed as a filler, thickener, binder, and stabilizer in ready-to-eat
products and convenience foods (Catassi & Fasano, 2008). Products that are devoid of
gluten have altered shape, quality, smell, and taste. Current practice in gluten-free
product production is to simply substitute gluten flour with maize, potato, or rice flour.
Pseudo-cereals such as amaranth, buckwheat, and quinoa are also employed, and are used
to make bread products with different crumb textures and tastes. With increasing
incidence of celiac disease, the demand for gluten-free products is growing. Currently,
the market offers limited variety, and gluten-free products are more expensive then
gluten-based products such as macaroni, cake mixes, cookies, breakfast cereals, and
bread products. A study from the British Journal of Nutrition found substantial
differences in price evident for gluten-free products when compared to their gluten-base
counterparts (Lee, et al., 2007). Gluten-free products are most readily available via the
Internet, followed by health-food stores, upscale grocery stores, and lastly in
supermarkets. This availability is also reflected in product prices. Supermarkets are the
most affordable source of gluten-free products; however, they also offer the least variety
of products (Lee, et al., 2007). The study also found regional differences in availability.
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The Northwest United States offers the most availability while the Southern region offers
the least availability of gluten-free products.
The gluten-free diet has different definitions depending on geographic location,
which affect the type and variety of products that are sold. In the United States, there is
currently no federal definition of gluten-free; however, the U.S. Food and Drug
Administration proposes that less than 20 ppm of gluten as safe for people with celiac
disease (Niewinski, 2008). In the United States, gluten-free diets are based on complete
elimination of wheat, rye, barley, and sometimes oats from the diet. It focuses on
naturally gluten-free products such as fruits, vegetables, and unprocessed meats. It also
focuses on incorporating different grains as substitutions for the gluten proteins in
products that are normally wheat-based such as pastas, breads, cereals, and crackers. In
the United Kingdom, gluten-free products focus on the biochemical elimination of gliadin
molecules from wheat-based foods. Most European nations follow the CODEX
Alimentarius Food Trade Guidelines that specify less than 20 ppm of gluten in naturally
gluten-free products as safe and less than 200 ppm of gluten in products containing
ingredients from wheat, rye, or barley as safe for people with celiac disease (Hall, Rubin,
& Charnock, 2009; Niewinski, 2008). It is considered safe to consume wheat, rye, and
barley products assuming they have been modified to deamidate the prolamine fractions
(Gallagher, Gormley, & Arendt, 2004).
Wheat is a staple food in many regions of the world (Catassi & Fasano, 2008).
Complete elimination of gluten from the diet is practically burdensome, restrictive, and
expensive. Approximately 60% of individuals with celiac disease are noncompliant, or at
least partially noncompliant, in following a strict gluten-free diet (Hall, et al., 2009). It is
difficult to determine the root cause of noncompliance with the gluten-free diet.
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Accidental ingestion of gluten is also a strong possibility since gluten is often used in
products that are not considered food such as cosmetics, lipstick, and toothpaste
(Kaukinen, et al., 2010). Noncompliance has been linked to factors such as cognitive,
emotional, and socio-cultural influences. It has also been shown that access to registered
dietitians and celiac disease support groups greatly enhances adherence to the diet (Hall,
et al., 2009). Many patients however do not trust their health care professional and
continue trying home methods to eliminate symptoms. Another factor affecting
compliance is availability of gluten-free products (Lee, et al., 2007). Compliance to the
gluten-free diet is lowest among ethnic minorities and teenagers (Hall, et al., 2009). It
has also been shown that children diagnosed with celiac disease have good compliance as
their meals are controlled by their caregivers; compliance tends to wane in these children
as they reach adolescence and adulthood. Compliance of the gluten-free diet is important
for individuals with celiac disease to control symptoms and prevent damage to the small
intestine.
Flax
Flax (Linum usitatissimum) and flaxseed oil have been important crops in
agriculture for thousands of years and are cultivated around the world. It has been used
not only for its nutrient properties as food, but also for its functional fibers. The use of
flax dates to as early as 5000 B.C. as one of the first crops to be domesticated by man.
Worldwide, it has been employed for not only its nutritional properties, cloth-making and
medicinal properties, but also for industrial capabilities. This crop is thought to have
originated in the Mediterranean areas and northern Africa. The ancient Egyptians used it
to produce fine linens that were used for preserving their dead. It is documented that
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Hippocrates used flax for the treatment of abdominal pain and as a laxative.
Charlemagne was so impressed by the nutritional properties of flax that he made it law
that his subjects consume it every day. There are also accounts of the use of flax and
flaxseed oil for cough relief, as a diuretic, wound-healing, and some gynecological
treatments (Tolkachev & Zhuchenko Jr., 2000).
The versatility of flax and flaxseed oil comes from its biochemical and structural
properties. Flax is an annual flower that produces seeds that posses a nutrient dense
chemical breakdown. The seeds have a chewy texture and nutty flavor (Carter, 1993).
Two varieties of seeds are available: yellow and brown, which are similar in nutrient
profile. Oil can be extracted from the seeds using a cold-press method and has many
useful applications. It is also possible to use a cold carbon dioxide treatment to extract
the oils (Tolkachev & Zhuchenko Jr., 2000).
Flax has many uses in the chemical industry and agriculture. Industrially,
flaxseed oil is known as linseed; this oil can be used to formulate asphalt, paints,
varnishes, and linoleums. Other products made from flax include paper, fishnets, and
personal products such as hair gel and soap. Until the invention of the cotton gin, it was a
primary source of fibers for fabric production. Flax is also a popular additive to livestock
feed because of its relative low cost and high protein content. Cheap and high in protein,
flax can also allow for change in nutrient ratio of agricultural output. The addition of flax
to livestock feed is common because it improves the coat luster of show animals. There
was demonstrated improvement in the ratio of linoleic to alpha-linolenic acid in eggs
when hens were fed flaxseed (Sims, McGregor, Plessers, & Mess, 1961).
Flax has recently been classified as a functional food (Pan, et al., 2009) because it
has a high content of fiber and the essential fatty acid alpha-linolenic acid. It also is a
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rich source of polyunsaturated fats and protein. The nutrient analysis of flaxseed is 41%
fat, 20% protein, and 28% fiber. The fatty acid composition of flax is unique and
contains a relatively low amount of saturated fat (9%), 18% monounsaturated fat, and the
remaining is polyunsaturated fat with 16% linoleic acid and 57% alpha-linolenic acid
(McDonald, 1994). The ratio of linoleic acid to alpha-linolenic acid is approximately
0.3:1. It contains the highest amount of alpha-linoleic acid of any of the major seed oils.
The protein component of flax is approximately 20gm/100gms of flax and has a
biological value similar to that of soy. It contains all essential amino acids for humans.
Flax is also a rich source of potassium, with equivalence to bananas per serving. It is also
a good source of magnesium, iron, copper, and zinc. Flax provides 28gm/100gms of
fiber with approximately 66% water insoluble cellulose and lignin. The water soluble
portion of flax fiber comes from the gum mucilage of the seed coat (Carter, 1993). Flax
also has a high content of lignans, which are structural phytochemicals that exert weak
estrogenic activity.
The plant material lignan in flax owes its functional properties partially to
secoisolariciresinol diglycoside (SDG). This phytochemical is present in the husk
coating of the flax plant and is in similar plants such as soybeans, seeds, whole grains,
barley, buckwheat, millet, and legumes. However, flax is the richest source of this
compound. When digested, gut flora are able to ferment SDG into enterolactone and
enterodial. These compounds have been shown to have anti-cancer effects in estrogenrelated cancers (Thompson, Robb, Serraino, & Cheung, 1991). They are able to block
cellular pathways that lead to the production of mutated cells and are also able to inhibit
protein synthesis that leads to metastasis of cancer in different types of tissue including
breast, colon, ovary, and prostate (Adolphe, Whiting, Juurlink, Thorpe, & Alcorn, 2010).
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Similar pathways have indicated that lignan compounds down-regulate gene expression
of other cancerous growth factors by competitive inhibition (Kaminski, Jendraschak,
Kiefl, & von Schacky, 1993).
Alpha-Linolenic Acid
The fatty acid component of flax gives it many functional properties. It is a rich
plant source of polyunsaturated fatty acids, mainly alpha-linolenic acid. This omegathree fatty acid is essential to the diet. It cannot be endogenously synthesized and must
be obtained from the diet. Food sources of alpha-linolenic acid include leafy green
vegetables, cold water fish, flax, nuts, and vegetable oils; however, the concentration of
alpha-linolenic acid is low in green plants. Deficiency in alpha-linolenic acid or linoleic
acid (an omega-six fatty acid), can have adverse consequences on cell membrane
integrity. It can present in patients with impaired growth, dermatitis, and neurological
disorders (Steel, Ryd, Ascher, & Strandvik, 2006) and reproductive disorders. Maternal
deficiency during pregnancy can lead to fetal brain and retinal deformities. It is
especially common in individuals with chronic gastrointestinal disorders such as celiac
disease. In this case, lipid malabsorption is not only the leading cause of deficiency, but
occurs secondarily to this deficiency since there is a decrease in absorptive integrity. In
this way, essential fatty acid deficiency is self-perpetuating.
While both of the essential fatty acids, alpha-linolenic and linoleic acids, are
important in the diet, an increasing body of evidence is suggesting that the Western diet
receives an excess amount of linoleic acid and quantities of alpha-linolenic acid are too
low. In the Paleolithic Age, these essential fatty acids were consumed in equal amounts,
but as dietary practices have changed (even over the past one hundred fifty years), a
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substantial change in ratio has occurred (Simopoulos, 1996). This conversion to a higher
amount of linoleic acid has been associated with chronic degenerative diseases such as
rheumatoid and osteo-arthritis because of its relationship essential to inflammation.
Prostaglandins are formed from cell membrane phospholipids when injury occurs.
Different prostaglandins are formed from alpha-linolenic and linoleic acids. The ones
formed from linoleic acid are pro-inflammatory and those formed from alpha-linolenic
acid are inflammatory to a lesser extent and even possess anti-inflammatory properties.
This gives strength to the argument for supplementation of omega-three, or alphalinolenic, acid.
Flax has a high correlation to anti-inflammation due to its content of
polyunsaturated fatty acids, which control the metabolism of prostaglandins mainly due
to its alpha-linolenic acid content (Mostofsky & Yehuda, 1997). The alpha-linolenic acid
present in flax exhibits anti-inflammatory properties when available in the body.
Inflammation is the body’s response to stress and involves several reactions and
biomarkers. The usual components of inflammation are increased blood flow, and
increased permeability across capillary walls allowing antibodies and cytokines to travel
from the blood to the infected tissue. Inflammation can be local or systemic. When
systemic inflammation gets out of control, a condition called systemic inflammatory
response syndrome (SIRS) is present; when this occurs, cytokines tissue necrosis factor
(TNF), interleukin-6 (IL6), and interleukin-8 (IL8) are out of control and destroy the
body’s own tissues. This systemic or local inflammation, while having a main goal of
protecting the body, can have deleterious effects over time. Chronic inflammation has
been linked to degenerative joint disease, systemic lupus erythemis, asthma, food
allergies, and heart disease (Allan & Devereux, 2011). The management of inflammation
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with diet has been studied. Kelly et al. (1991) noticed that these oils are useful in
suppressing cell-mediated immunity without affecting the humoral response, which
would allow the body to still defend itself from foreign bodies.
Alpha-linolenic acid affects immune response in several ways. First, it affects
inflammation within the cellular membrane. The components of the cell membrane are
phospholipids; the chemical breakdown of each cell membrane is affected by the fatty
acids obtained from the diet. The alpha-linolenic acid to linolenic acid ratio of fatty acids
in the membrane affects the permeability of cytokines that promote inflammation. A
higher concentration of alpha-linolenic acid in the phospholipid membrane physically
inhibits the action of some cytokines. Current dietary consumption patterns of linoleic
acid to alpha-linolenic acid are approximately 20-30:1 (Simopoulos, 1999). This change
in membrane composition also gives rise to different eicosanoids. Eicosanoids are
inflammatory and immune signaling molecules, derived from 20-carbon polyunsaturated
fatty acids that are produced on demand from phospholipid membranes when injury
occurs. Eicosanoids then trigger inflammatory markers called prostaglandins. These
eicosanoids are derived from alpha-linolenic acid and linolenic acid. Arachonidoic acid
is an eicosanoid derived from linoleic acid phospholipids and eicosapentaenoic acid
(EPA), and docosahexaenoic acid (DHA) is an eicosanoid derived from alpha-linolenic
acid. In general, arachonidoic acid has proinflammatory functions while EPA and DHA
have anti-inflammatory properties. Increased alpha-linolenic acid concentration in the
phospholipid membrane allows greater production of anti-inflammatory eicosanoids.
Linoleic acid and its derived eicosanoids function in immune response by
promoting inflammation. If linoleic acid is excessive in the diet, there will be a direct
proportional excess in the cell membrane. This allows for the creating of arachonidoic
23

acid, which is the dominant substrate when eicosanoids are produced. Large amounts of
omega-six fatty acids can cause chronic inflammation in states of stress and can
exacerbate other states of inflammation. Hyperinflammation can even occur, especially
in immunosuppressed individuals. The signal for the production of cytokine TNF is
stimulated by prostaglandins, which are arachonidoic acid metabolites. This TNF upregulates inflammatory leukocytes leading to further local inflammation and possibly
systemic response syndrome (Tull, et al., 2009). C-reactive proteins, which are markers
for inflammation, have been demonstrated to be reduced with supplementation of alphalinolenic acid (Renaud & Lanzmann-Petithory, 2002). The use of omega-three fish oils
and plant-derived flax oils are currently being employed in situations of artificial
nutrition (Calder, 2010). Essential fatty acids have been incorporated into enteral
formulas and parenteral intravenous nutrition regimens. It was reported that the essential
fatty acids induced a decline in antigen-presenting cells and demonstrated clinical
improvement in surgical patients requiring either enteral or parenteral nutrition (Calder,
2010).
Consumption of alpha-linolenic acid demonstrated many benefits to heart health
such as positively affecting serum cholesterol levels, lowering blood pressure in
hypertensive individuals, decreasing platelet-cell aggregation, anti-arrhythmic effects,
and electrolyte stabilization. Anti-atherosclerotic effects are also demonstrated by
decreased incidence of inflammation. A meta-analysis by Pan et al. (2009) on the effects
of flax supplementation revealed that dietary supplementation with alpha-linolenic acid
from flax in food products consistently had a major impact on cholesterol and cholesterol
ratios. Researchers found a consistent decrease in LDL cholesterol when patients were
supplemented with 15gms of flaxseed oil-containing products (Pan, et al., 2009).
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However, with flax oil, they noted that HDL and total cholesterol were only marginally
decreased. Researchers noted that there was a consistent substantial decrease in LDL and
total cholesterol when whole or milled flax seed was involved. This is probably due to
additional functional characteristics present in the flaxseed such as lignans and fiber. The
fiber is soluble, which has a known cholesterol lowering effect. These results were most
significant in those with mildly elevated blood lipids, men and postmenopausal women
(Pan, et al., 2009). Bierenbaum, Reichstein, and Walkins (1993) reported similar results
when participants consumed bread containing 15gm of flax/day for three months. After
three months, the participants total cholesterol concentrations decreased by 10%, and
HDL was not significantly affected.
Perhaps one of the most well known studies on dietary effects on heart health was
the Lyon Diet Heart Study: a randomized secondary prevention trial by de Lorgeril,
Salen, Martin, Monjaud, Boucher, and Mamelle (1998). The study did not focus on flax
in general, but the Mediterranean diet, which is rich in alpha-linolenic acid. This study
found that a Mediterranean-style diet not only was preventative in the development of
coronary artery disease, but also significantly prevented future occurrences after a cardiac
event. While the benefits of the Mediterranean diet cannot be fully attributed to alphalinolenic acid, several other components of the diet are represented in flax such as fiber,
natural antioxidants, and low linoleic acid/alpha-linolenic acid ratios. It has also been
demonstrated that the high potassium intake of a flax-containing diet was inversely
related to stroke incidence, blood platelet aggregation, and presence of oxygenscavenging free radicals in blood (Carter, 1993). It has been suggested that those at risk
or with family history risk factors of coronary artery disease should adopt a
Mediterranean-style diet pattern (de Lorgeril, Salen, & Matin, 1996). While the full
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benefits are not clearly understood, as well as the single effect of alpha-linolenic acid,
there are substantial positive and relatively no deleterious side effects. A meta-analysis
by Howe (2006) reported blood pressure in individuals (both men and women) was
positively affected from diets rich in polyunsaturated fats. A -3.4/-2.0mmHg decrease
was noted in hypertensive subjects that consumed 5.6gms of alpha-linolenic acid per day
(Howe, 2006). In comparison of linoleic and alpha-linolenic acids, alpha-linolenic acid
has the ability to act as a vasodilator. Howe (2006) also contributes the increased
vascular surface area to decreased production of arachonidoic acid, which is inhibited by
diets with favorable linoleic acid/alpha-linolenic acid ratios.
The increase in the alpha-linolenic acid to linoleic acid ratios seems to have the
greatest effect on blood and blood systems as well as endothelium membrane integrity
(Simopoulos, 2008). Cawood and colleagues (2010) found that vessels with higher levels
of alpha-linolenic acid in the actual atherosclerotic plaque were less inflamed than vessels
with low alpha-linolenic acid-plaque concentration. This decrease in inflammation leads
to more stable vessels that are less likely to rupture spontaneously. Histologically, the
alpha-linolenic acid content was inversely related to the amount of T-cells present in the
vessels (Cawood, et al., 2010).
Flax owes much of its anti-carcinogenic capabilities to its lignan content. Lignans
are phytoestrogens, or plant-based materials that have weak estrogenic activity in
mammals. These compounds are also found in soybeans, barley, buckwheat, millet, and
oats; however, flax is the richest plant source. The functional component of
phytoestrogen in flax is SDG, which is a precursor for estrogen-like materials. This
compound is ingested and fermented by gut flora into enterodial and enterolactone in the
colon. These metabolites are structurally and chemically similar to estrogen and can bind
26

normal estrogen receptors. This can cause the inhibition of estrogen-stimulated cancer
cells such as breast cancer (Thompson, et al., 1991). Enterodial and enterolactone reduce
the risk of cancer by preventing precancerous cellular changes and preventing cell
proliferation. The cancerous cells can then be destroyed by the immune system. They
can also prevent the metastasis of cancer cells to different tissues and organs (Adolphe, et
al., 2010). Thompson and Cunnane (2003) noted increased urinary excretion of
enterolactone and enterodial, which was directly related to dietary intake. This urinary
excretion was noted to be reduced in women with breast cancer whereas consumption of
flax increased urinary concentration of lignans (Thompson & Cunnane, 2003).
While lignans play an important role in reducing the risk of cancers, their antiinflammatory properties can also be credited with tumor cell prevention. Dietary alphalinolenic acid has been shown to down-regulate gene expression of potent carcinogenic
growth factors (Kaminski, et al., 1993). In a study by Cave (1991), it was demonstrated
that supplemental alpha-linolenic acid suppressed tumor growth in experimental models.
Cave (1991) also demonstrated that diets high in linoleic acid were able to enhance tumor
cell development. Tumor growth requires specific conditions to grow and metastasize. It
requires immune factors such as leukotrienes and prostaglandins and specific cellular
environments to compete their pathway to spreading. Luekotrienes and prostaglandins
are inflammatory markers that are related to tumor cell growth and inflammation. These
can be modified by supplementation with alpha-linolenic acid and a decrease in
consumption of linoleic acid.
While benefits to cardiovascular health, cancer, and inflammation are key benefits
of flax consumption, various other health benefits have been noted. Laxation and bowel
movement frequency were shown to improve in elderly patients after consuming flax
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muffins for seven days (Hamadeh, Liede, Sanguli, Wolever, & Cunnane, 1992). This
improvement is also partially due to the high amount of insoluble fiber present in the flax
seed. Some studies have linked flax to improved glucose control. Post-prandial blood
glucose levels were reduced 27% in response to consumption of glucose and flax
simultaneously (Cunnane, Hamadeh, Liede, Thompson, & Wolever, 1995).
Flax as an Ingredient
Flax is a versatile food ingredient that has been used in cookery for thousands of
years with applications in whole form and in oil (Dremucheva, Plandova, & Bessonova,
1995). It has a high protein, fiber, and oil content making it an excellent choice as a food
additive. Currently it is used in products such as breakfast cereals, salad dressings, meat
extenders, crackers, soups, bagels, and cakes (Carter, 1993). One of the most common
vehicles for flax employment is baked products (Craig, 1999). Pseudo-flour can be
formed from the milling of flax seeds. This flour provides a strong texture and a rich
nutty flavor that works well in enhancing the flavor of leavened breads, waffles, and
pancakes when it comprises approximately 6-8% of the dry ingredients (Carter, 1993).
Flax is also a vegetarian-friendly source of protein that has functional properties similar
to that of soy protein isolates. The protein fraction of flax has a digestibility of 85-90%.
Flax can also be used as an egg substitute in bakery products providing a
cholesterol-free fat additive with similar chemical qualities (Meuller, Eisner, YoshieStark, Nakada, & Kirchhoff, 2010). While not useful for deep frying (due it its relatively
low smoke point of 225°F), the use of flax oil for stir frying is common practice in China
(Pan, 1990). While “generally recognized as safe (GRAS) status” has not yet been
reached by flax, the U. S. Food and Drug Administration has made no objection in its use
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up to 12%. Flaxseed’s unique chemical and nutritional profiles make it an excellent food
ingredient. The pseudo-flour derived from flax has been noted to have a gummy texture
(Carter, 1993). This unique texture allows for enhanced viscosity and can be seen as
favorable in certain products. Flaxseed products also have an excellent water and oil
binding capacity that allows them to maintain moisture and freshness (Krause, Schultz, &
Dudek, 2002). Unfortunately, this causes flax to have a relatively short shelf-life. In
terms of nutritional quality stability, flaxseed-derived SDG was stable in baked products
with no significant losses during processing or storage for one week at room temperature,
or frozen for one to two months (Hyvarinen, et al., 2006).
While an increasing number of studies involving flax-fortified products are
beginning to be seen in the literature, there are also studies involving sensory properties
of gluten-free products. However, to date, no studies have been identified that focus on
gluten-free products fortified with flax. It was demonstrated that the muffin was an
excellent vehicle for flax supplementation of up to 50gm/day (Cunnane, et al., 1995).
One study from Trinidad and Tobago found that flax decreased consumer acceptability of
muffins; however, the products tested were not gluten-free (Ramcharitar, Badrie,
Mattfeld-Beman, Matsuo, & Ridley, 2005). Another study reported that there was
limited to no difference in consumer acceptability of banana nut muffins and oatmeal
cookies fortified with flax (Alpers & Sawyer-Morse, 1996). To date, no studies have
been identified that evaluated the sensory properties of gluten-free flax-fortified products.
Sensory Analysis
Sensory analysis is a method used to test human perception of a product. Product
perception not only induces a consumer to initially purchase the product, but to also
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purchase the product again. This technique allows products to be developed that will
likely be sold based on the theory that the perception of a sample of individuals tasting a
product can be extrapolated to a population (Meilgaard, Carr, & Civille, 2007). Sensory
analysis generally involves placing participants in a private area and providing them with
variable treatments of the product being tested. The panelists are often asked to complete
a survey of their perception of each sample. Common perceptional inquiries include
flavor, aroma, texture, and appearance (Meilgaard, et al., 2007), which can serve as
dependent variables. This can allow the researcher to change specific attributes (in this
case, the presence and amount of flax) and determine how the specific amounts being
tested relate to sensory acceptability.
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CHAPTER III
MATERIALS AND METHODS
Muffin Formulation
A basic gluten-free muffin recipe was adapted from Bob’s Red Mill™ website
(Bob's Red Mill Natural Foods, n.d.). This recipe was formulated using gluten-free
baking flour formulated by Glutino™. This baking mix was a formulation of cereals
including white rice flour, potato starch, and tapioca starch to provide structural proteins.
It was decided to develop plain spice muffins in order to eliminate pre-conceived
consumer biases related to additional ingredients commonly associated with muffins
(frosting, fruit, etc). The ingredients of the recipe were listed in English standard
measurements, and thus were converted to metric units. Table 1 lists the ingredients
included in the muffins.
Preliminary testing was conducted in the Garrison Sensory Evaluation Laboratory
in the Department of Food Science, Nutrition, and Health Promotion at Mississippi State
University in order to determine appropriate amounts of milled flax to add to the muffins.
It was determined that a 3.8% milled-flax concentration would serve as an appropriate
moderate amount in muffins and 7.4% milled-flax concentration would serve as an
appropriate high-flax muffin based on previous literature (Cunnane, et al., 1995;
Ramcharitar, et al., 2005) along with perception of the preliminary panelists. These
amounts of flax provided a noticeable difference and still had an acceptable taste. This
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study incorporated flax into gluten-free muffins in order to incorporate alpha-linolenic
acid for supplementation into baked products.
Table 1

Ingredients for gluten-free muffins with added flax.

Ingredients
Brand
Gluten-free all purpose-flour Glutino Gluten Free Pantry®
Sugar
Kroger® brand
Baking powder
Clabber Girl®
Nonfat dry milk
Kroger® brand
Dried Egg White Powder
Deb El™
Cinnamon
Kroger® brand
Nutmeg
McCormick®
Cloves
McCormick®
Salt
Morton®
Water
Canola Oil
Kroger® brand
Vanilla Extract
Simply Organic®
Milled Flax Seed
Bob’s Red Mill®

Amount
400gm
150gm
20gm
20gm
10gm
4gm
2gm
2gm
2gm
550mL
80gm
10gm
0gms, control
(0.0%)
50gms, moderateflax (3.8%)
100gms, high-flax
(7.4%)

To prepare the muffins, the muffin method was utilized (Labensky & Hause,
2006) and all ingredients were gathered in a mis-en-place fashion. A Viking™ gas-range
dual-burner convection oven was preheated to 325°F (163°C). A convection oven was
employed to produce even heating of the muffins and a more consistent product (Molt,
1997). Three mini-muffin pans were greased with Pam™ No-stick cooking spray
providing a total of 72 muffin slots. The dry ingredients were weighed on a tared digital
kitchen scale (Denver Inst. Company TL-603) including the gluten-free flour, sugar,
baking powder, egg white powder, nutmeg, cloves, salt, and cinnamon. The independent
variable was flax and muffins containing flax included 50gms and 100gms of milled flax,
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respectively. Once weighed, the ingredients were placed in a large mixing bowl and
gently sifted. The wet ingredients included canola oil, vanilla extract, and water. The
canola oil and vanilla extract were weighed into a separate bowl and 550mL of water
were added. A well was made in the center of the dry ingredients and the liquid solution
was added. In order to avoid tunneling, the batter was stirred a total of fifty times. It was
still lumpy, a trait consistent with the muffin method. A #16 dipper was used to place
approximately 2 ounces of batter in the muffin wells (Molt, 1997). The muffin wells
were approximately 2/3 full and each batch of batter produced 72 small muffins. The
muffins were then baked for 17 min. At the end of 17 min, a toothpick was inserted into
the center of a muffin to ensure doneness of the batter. The muffins were left to cool in
the wells for 10 min. After 10 min, they were placed into small plastic ramekins with
their assigned 3-digit random number.
Nutrient analysis of the muffins was performed using the U.S. Department of
Agriculture nutrient database for standard reference (U.S. Department of Agriculture,
Agricultural Research Service, 2010).
Institutional Review Board Approval
Approval from the Mississippi State University Institutional Review Board was
obtained (#10-161) on October 11, 2010 (Appendix A). This was completed to ensure
protection of human subjects that would be participating in taste panels. Written consent
was provided from all panelists prior to tasting the muffins (Appendix B). This consent
expressed the purpose of the research project, confidentiality policies, notification of
voluntary participation, and contact information of the researchers. A complete list of
ingredients was also provided to ensure protection against food-related reactions.
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Sensory Analysis
The sensory panels were set-up in assembly-line fashion. The muffin samples
were placed into three plastic ramekins with their perspective random number printed on
the side of the ramekin. The tasting booths were private and panelists could push a
button that lit up on the other side of the panel booth if they had questions. Sensory
analysis of the muffins was performed at the Garrison Sensory Evaluation Laboratory at
Mississippi State University. The panelists provided consent upon entry to the
laboratory. The panelists entered the booth and were presented three different muffin
samples, a glass of water, an expectorant cup, a napkin, a pencil, and a score sheet/survey
(Appendix C). The lighting condition in the booths was white overhead lighting.
The panelists were asked to provide demographic information including gender,
age, frequency of consumption of gluten-free products, preferences of muffins, and
muffin-type preference. They were then instructed to taste each sample and rate
appearance, aroma, flavor, texture, and overall acceptability on a scale of 1-9. A Hedonic
rating scale was employed as follows: 1=dislike extremely, 2=dislike very much,
3=dislike moderately, 4=dislike slightly, 5=neither like nor dislike, 6=like slightly, 7=like
moderately, 8=like very much, and 9=like extremely (Meilgaard et al., 2007). Score
sheets/surveys listed the three samples in different order to provide more consistent
ranking among all three trials and to prevent bias. A space for additional comments was
also provided on the score sheet/survey (Appendix C). The samples presented contained
a control muffin, a moderate-flax muffin, and a high-flax muffin. The samples were
placed in covered plastic ramekins and assigned randomly-generated 3-digit numbers to
control for consumer number association. The random numbers are presented in Table 2.
Between tasting each sample, panelists were asked to expectorate the sample in a cup
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provided or swallow the sample. This taste panel was repeated on three different days
from approximately 10:30am-1:00pm. Each trial consisted of at least 50 panelists.
Table 2

Random numbers assigned to each treatment.

Treatment
Control
Moderate-flax
High-flax

1st panel
131
498
389

2nd panel
335
154
928

3rd panel
245
416
795

Statistical Analysis
Statistical analysis of the data was performed using SAS (version 9.1.2, 2005). A
randomized complete block design with three replications/panels (n>50 per
replication/panel) was used to determine if differences existed among treatments.
Significance was determined at a p value of less than 0.05. When significant differences
occurred (p<0.05), the Fisher’s Protected Least Significant Difference (LSD) test was
used to separate treatment means. Cluster analysis was conducted to group consumers
together according to their preference and liking of treatments. Consumers were grouped
into clusters based on results of the dendrogram and dissimilarity plot and differences
(p<0.05) were determined between treatments among clusters. Demographic data were
analyzed using SPSS (version 18.0, 2010). Age of participants is reported as years +
standard deviation (SD).
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CHAPTER IV
RESULTS AND DISCUSSION
The survey (Appendix C) inquired basic demographic information including age
and gender. Other inquiries on the survey included consumption of gluten-free products,
likeness of muffins, and types of muffins liked. Participants (N=152) ranged in age from
19 to 63 years old with a mean age of 32.2 years old + 12.5 SD. Of the panelists, 70.2%
were female. When asked whether or not you consume gluten-free products, 20.9% of
the participants indicated “yes.” The panelists were also asked how well they like
muffins in general (Table 3); the mean score was 4.6 ± 0.6 SD on a five-point Likert
Scale (1=No, dislike very much, 3=neither like nor dislike 5=Yes, like very much). A
majority (96%) of the panelists indicated that they either like muffins “very much” or
“like somewhat.” Only two panelists indicated that they had any distaste for muffins and
four panelists indicated that they “neither like nor dislike” muffins.
Table 3

Panelists’ responses to: “Do you like muffins?”

n
%
Very much
95
63
Like somewhat
49
33
Neither like nor dislike
4
3
Dislike somewhat
1
1
Dislike very much
1
1
(1=No, dislike very much, 3=neither like nor dislike, 5=Yes, like very much)
The panelists were asked which types of muffins they liked (Table 4). It was
determined that blueberry and cake-like muffins were ranked the highest with 77.0% and
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67.1%, respectively. Banana-nut muffins were followed with 62.5% of panelists
indicating that they liked these. Spice muffins, the muffin vehicle for this study, ranked
next with 42.8% of panelists indicating predilection. Bran muffins followed by plain
muffins received the lowest levels of consumer propensity with 38.2% and 32.9%,
respectively, indicating that they also liked these muffins. Other muffins liked were
indicated by 23.7% panelists and not listed on the survey (Appendix C), but were written
in by panelists and included sweet potato muffins, oat muffins, and lemon-poppyseed
muffins. Based on this data, the panelists tended to like sweeter-tasting muffins with
added ingredients such as fruit and sugar over traditional dinner muffins.
Table 4

Plain Muffin
Bran Muffin
Cake-like
Banana Nut
Blueberry
Spice
other

Percentage of consumers that like different types of muffins.
Yes
(n)
50
58
102
95
117
65
36

Yes (%) No (n)

No (%)

32.9
38.2
67.1
62.5
77.0
42.8
23.7

67.1
61.8
32.9
37.5
23.0
57.2
76.3

102
94
50
57
35
87
116

Differences (p<0.05) in sensory properties were observed in appearance, flavor
and overall acceptability of the gluten-free muffins with added flax, while no differences
(p>0.05) were observed in aroma or texture (Table 5). On average, the panelists liked the
appearance of the control muffins more (p<0.05) than muffins from the moderate- and
high-flax treatments. This indicates that use of flax has a slightly negative impact on the
acceptability of the muffins appearance. However, the appearance of all muffin
treatments were liked moderately, indicating that there was minimal practical difference
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in the appearance of muffins. The flavor of the control and high-flax muffins were liked
more (p<0.05) than the muffins from the moderate-flax treatment. The flavor of the
muffins was ranked lower in the moderate-flax treatment (p<0.05) but there was no
difference (p>0.05) between the control (no flax) and the high-flax muffin. Addition of
milled flax generally gives baked products a rich, nutty flavor which is considered
favorable in leavened breads and also quick breads, including muffins (Carter, 1993). On
average, the mean scores for overall acceptability were consistent with flavor ratings in
subsequent treatments. The moderate-flax muffins were ranked lower (p<0.05) than the
control and high-flax muffins, but there was no difference (p>0.05) between the control
and high-flax muffins. These results are similar to those from a previous study in which
a 7.3% flax concentration was rated similarly to a 0% (no flax) control muffin
(Ramcharitar, et al., 2005). These results indicate that a higher concentration may
suggest an “all-or-nothing response” to the addition of milled flax to gluten-free muffins
for flavor and overall acceptability.
No difference (p>0.05) was observed between treatments with respect to the
acceptability of aroma and texture (Table 5). This is surprising considering that the
addition of milled flax generally produces a stronger, firmer texture when added to baked
products (Carter, 1993). Perhaps the oil-binding capacity of the milled flax allowed for
the softening characteristic of the fat to be perceived by consumers.
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Table 5

Mean scores for consumer acceptability (N=152) of gluten-free muffins
with three treatments.

Treatment
Appearance Aroma
Flavor
Texture
Overall Acceptability
a
a
a
a
Control (0% flax) 7.3
7.3
6.7
6.4
6.7a
Moderate flax
(3.8%)
7.0b
7.2a
6.3b
6.4a
6.4b
High flax (7.4%) 6.9b
7.4a
6.6a
6.6a
6.7a
a-b
Mean scores within a column with different letters are significantly different (p<0.05).
Scores were based on a Hedonic Scale: (1=dislike extremely, 2=dislike very much,
3=dislike moderately, 4=dislike slightly, 5=neither like nor dislike, 6=like slightly, 7=like
moderately, 8=like very much, 9=like extremely).
Cluster Analysis
Agglomerative hierarchical clustering was performed to further determine
attitudes of the consumers toward gluten-free muffins with added flax; this would allow
for determination of consumer groups that have similar liking and preferences of muffins
based on similar survey responses. A dendrogram and dissimilarity plot were generated
to determine commonalities among panelists. It was determined by cluster analysis that
there were five distinct groups of panelists (Table 6).
Table 6

Cluster

Mean scores for consumer acceptability of gluten-free muffins according to
different clusters of consumer segments.
Consumers Consumers
(n)
(%)
Control Moderate-flax
a

b

High-flax

1

21

14.3

7.2

5.1

7.3a

2
3

79
11

52.7
7.5

7.5a
2.9

7.5a
3.0

7.5a
4.3

4
26
17.7
6.2a
5.5b
4.9b
5
10
6.8
4.4
5.7
7.0
Mean scores within a row with different letters are significantly different (p<0.05)
Scores were based on a Hedonic Scale: (1=dislike extremely, 2=dislike very much,
3=dislike moderately, 4=dislike slightly, 5=neither like nor dislike, 6=like slightly, 7=like
moderately, 8=like very much, 9=like extremely).
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Panelists from cluster one (n=21, 14.3%) liked the control and high-flax
treatments moderately and preferred (p<0.05) muffins from these treatments over the
control treatment, which was neither liked nor disliked. Panelists from cluster two
(52.7%) liked all muffin treatments between “like moderately” and “like very much.”
This was the largest group of consumers, and this group has a high degree of liking for
muffins made with and without flax. Panelists from cluster three did not like muffins
from any treatment, and is therefore not representative of consumers who like gluten-free
muffins. Cluster four, which contained 17.7% of the panelists, preferred only the control
muffins (p<0.05) over the flax treatments, and acceptability decreased as flax percentage
increased in the sample. These consumers did not like the sensory properties that flax
imparted to the muffins. Panelists from cluster five (6.8%) liked muffins more as flax
percentage increased and therefore liked the sensory properties that flax imparted to the
muffins. Results further indicate that 92% of the panelists that liked at least one muffin
treatment liked the control muffins, 81% of the panelists that liked at least one muffin
treatment liked the high-flax treatment, and 57% of these panelists liked the moderateflax treatment. This indicates that a high percentage of consumers that like the muffin
treatments would like muffins from the control or high-flax treatment.
Nutrient Analysis
The control muffins contained 69.3% carbohydrate, 4.0% protein, and 26.7% fat
with relatively no fiber. The addition of milled flax in the moderate-flax treatment (3.8%
milled flax) contributed relatively few kcal, grams of fat, protein, and small amount of
fibrous carbohydrates changing the nutrient ratios to 65.7% carbohydrate, 5.5% protein,
and 28.8% fat with additional 64mg alpha-linolenic acid per muffin. The final
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composition of the moderate-flax treatment was 66% carbohydrate, 6% protein, and 28%
fat. The high-flax treatment (7.4% milled flax) also contributed relatively few kcal,
grams of fat, protein, and small amount of fibrous carbohydrates changing the nutrient
ratios to 62.7% carbohydrate, 6.8% protein, and 30.5% fat with additional 129mg alphalinolenic acid per muffin (U.S. Department of Agriculture, Agricultural Research Service,
2010).
Limitations of Study
While it was originally thought that a spice muffin would provide a neutral but
well-accepted muffin for consumers, it may not have been the most appropriate choice
for testing sensory qualities of added flax. Some of the write-in comments from the
survey referred to “too strong nutmeg flavor” and “too much nutmeg.” This flavor may
have interfered with some panelists’ ability to differentiate properties of the treatment
being tested. Also, when questioned on types of muffins preferred, only 43% of the
panelists indicated that they liked spice muffins. Perhaps a different type of muffin such
as blueberry or banana nut would be appropriate vehicles for further study. Only 20.9%
of the panelists indicated that they ordinarily consumed gluten-free products. This
provides limitation because the target market for gluten-free products was not well
represented in this sample. These data may indicate lack of consumer preference for
gluten-free products, lack of consumer knowledge of gluten-free products, and lack of
overall availability of the products as stated in previous studies (Lee, et al., 2007).
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CHAPTER V
CONCLUSIONS
In this study, muffins were a successful vehicle for testing acceptance of flax
(Linum usitatissimum) added to a gluten-free baked product. Consumers were grouped
into five clusters based on how they rated the muffins for appearance, flavor, texture,
aroma, and overall acceptability. Overall, consumers preferred gluten-free muffins
without flax or antithetically high amounts of flax (7.4%); moderate amounts of flax
(3.8%) were liked less by panelists (p<0.05). This can allow producers of gluten-free
products to maximize nutritional properties along with consumer acceptance of glutenfree muffins. Applications for further study should include the use of different glutenfree flours. This study employed a blend of white rice flour, potato starch, and tapioca
starch. The characteristic flavor of each of these flours may have affected sensory
perception of the treatments. Also, it would be beneficial to experiment with different
types of muffins to eliminate possible consumer bias.
The findings of this study can be helpful for medical practitioners as well as food
manufacturers in recipe development for both home use and commercial preparation.
Registered dietitians can provide celiac patients with recipes that can not only be
tolerated without causing inflammation, but can incorporate nutrients into the diet that are
often lacking in diets requiring strict avoidance of gluten. Flax is an excellent source of
alpha-linolenic acid that can provide many nutritional benefits. Recipes with added flax
can utilize the functional properties of alpha-linolenic acid for disease prevention such as
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heart disease and cancer, and possible reduction in inflammation caused by gluten.
Future development of the gluten-free market is not only wide open and versatile, but
likely to receive more consumer attention considering the increasing incidence of celiac
disease.
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